Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 54

1.

Mesenchymal stem cell therapy in proteoglycan induced arthritis.

Swart JF, de Roock S, Hofhuis FM, Rozemuller H, van den Broek T, Moerer P, Broere F, van Wijk F, Kuis W, Prakken BJ, Martens AC, Wulffraat NM.

Ann Rheum Dis. 2015 Apr;74(4):769-77. doi: 10.1136/annrheumdis-2013-204147. Epub 2014 Jan 6.

PMID:
24395558
2.

Reconstructing the human hematopoietic niche in immunodeficient mice: opportunities for studying primary multiple myeloma.

Groen RW, Noort WA, Raymakers RA, Prins HJ, Aalders L, Hofhuis FM, Moerer P, van Velzen JF, Bloem AC, van Kessel B, Rozemuller H, van Binsbergen E, Buijs A, Yuan H, de Bruijn JD, de Weers M, Parren PW, Schuringa JJ, Lokhorst HM, Mutis T, Martens AC.

Blood. 2012 Jul 19;120(3):e9-e16. doi: 10.1182/blood-2012-03-414920. Epub 2012 May 31.

PMID:
22653974
3.

Protein kinase B (PKB/c-akt) regulates homing of hematopoietic progenitors through modulation of their adhesive and migratory properties.

Buitenhuis M, van der Linden E, Ulfman LH, Hofhuis FM, Bierings MB, Coffer PJ.

Blood. 2010 Sep 30;116(13):2373-84. doi: 10.1182/blood-2009-10-250258. Epub 2010 Jun 21.

PMID:
20566894
4.

T cell activation and proliferation characteristic for HIV-Nef transgenic mice is lymphopenia induced.

Koenen PG, Hofhuis FM, Oosterwegel MA, Tesselaar K.

J Immunol. 2007 May 1;178(9):5762-8.

5.

ICOS contributes to T cell expansion in CTLA-4 deficient mice.

van Berkel ME, Schrijver EH, Hofhuis FM, Sharpe AH, Coyle AJ, Broeren CP, Tesselaar K, Oosterwegel MA.

J Immunol. 2005 Jul 1;175(1):182-8.

6.

FcgammaRI (CD64) contributes substantially to severity of arthritis, hypersensitivity responses, and protection from bacterial infection.

Ioan-Facsinay A, de Kimpe SJ, Hellwig SM, van Lent PL, Hofhuis FM, van Ojik HH, Sedlik C, da Silveira SA, Gerber J, de Jong YF, Roozendaal R, Aarden LA, van den Berg WB, Saito T, Mosser D, Amigorena S, Izui S, van Ommen GJ, van Vugt M, van de Winkel JG, Verbeek JS.

Immunity. 2002 Mar;16(3):391-402.

7.

Arthritis critically dependent on innate immune system players.

Ji H, Ohmura K, Mahmood U, Lee DM, Hofhuis FM, Boackle SA, Takahashi K, Holers VM, Walport M, Gerard C, Ezekowitz A, Carroll MC, Brenner M, Weissleder R, Verbeek JS, Duchatelle V, Degott C, Benoist C, Mathis D.

Immunity. 2002 Feb;16(2):157-68.

8.

Consequences of gene targeting procedures for behavioural responses and morphological development of newborn mice.

van der Meer M, Baumans V, Hofhuis FM, Olivier B, van Zutphen BF.

Transgenic Res. 2001 Oct;10(5):399-408.

PMID:
11708650
9.

Markedly different pathogenicity of four immunoglobulin G isotype-switch variants of an antierythrocyte autoantibody is based on their capacity to interact in vivo with the low-affinity Fcgamma receptor III.

Fossati-Jimack L, Ioan-Facsinay A, Reininger L, Chicheportiche Y, Watanabe N, Saito T, Hofhuis FM, Gessner JE, Schiller C, Schmidt RE, Honjo T, Verbeek JS, Izui S.

J Exp Med. 2000 Apr 17;191(8):1293-302.

10.

Human immunoglobulin A receptor (FcalphaRI, CD89) function in transgenic mice requires both FcR gamma chain and CR3 (CD11b/CD18).

van Egmond M, van Vuuren AJ, Morton HC, van Spriel AB, Shen L, Hofhuis FM, Saito T, Mayadas TN, Verbeek JS, van de Winkel JG.

Blood. 1999 Jun 15;93(12):4387-94.

PMID:
10361137
11.

Murine IgG1 complexes trigger immune effector functions predominantly via Fc gamma RIII (CD16).

Hazenbos WL, Heijnen IA, Meyer D, Hofhuis FM, Renardel de Lavalette CR, Schmidt RE, Capel PJ, van de Winkel JG, Gessner JE, van den Berg TK, Verbeek JS.

J Immunol. 1998 Sep 15;161(6):3026-32.

12.

Impaired IgG-dependent anaphylaxis and Arthus reaction in Fc gamma RIII (CD16) deficient mice.

Hazenbos WL, Gessner JE, Hofhuis FM, Kuipers H, Meyer D, Heijnen IA, Schmidt RE, Sandor M, Capel PJ, Daëron M, van de Winkel JG, Verbeek JS.

Immunity. 1996 Aug;5(2):181-8.

13.

Antigen targeting to myeloid-specific human Fc gamma RI/CD64 triggers enhanced antibody responses in transgenic mice.

Heijnen IA, van Vugt MJ, Fanger NA, Graziano RF, de Wit TP, Hofhuis FM, Guyre PM, Capel PJ, Verbeek JS, van de Winkel JG.

J Clin Invest. 1996 Jan 15;97(2):331-8.

14.

Increased susceptibility to ultraviolet-B and carcinogens of mice lacking the DNA excision repair gene XPA.

de Vries A, van Oostrom CT, Hofhuis FM, Dortant PM, Berg RJ, de Gruijl FR, Wester PW, van Kreijl CF, Capel PJ, van Steeg H, Verbeek SJ.

Nature. 1995 Sep 14;377(6545):169-73.

PMID:
7675086
15.

Intra- and extracellular amyloid fibrils are formed in cultured pancreatic islets of transgenic mice expressing human islet amyloid polypeptide.

de Koning EJ, Morris ER, Hofhuis FM, Posthuma G, Höppener JW, Morris JF, Capel PJ, Clark A, Verbeek JS.

Proc Natl Acad Sci U S A. 1994 Aug 30;91(18):8467-71.

16.

Chronic overproduction of islet amyloid polypeptide/amylin in transgenic mice: lysosomal localization of human islet amyloid polypeptide and lack of marked hyperglycaemia or hyperinsulinaemia.

Höppener JW, Verbeek JS, de Koning EJ, Oosterwijk C, van Hulst KL, Visser-Vernooy HJ, Hofhuis FM, van Gaalen S, Berends MJ, Hackeng WH, et al.

Diabetologia. 1993 Dec;36(12):1258-65.

PMID:
8307253
17.

Immunoadjuvant activity of a liposomal IL-6 formulation.

Duits AJ, van Puijenbroek A, Vermeulen H, Hofhuis FM, van de Winkel JG, Capel PJ.

Vaccine. 1993;11(7):777-81.

PMID:
8342326
18.

Induction of active immunological hypo/non-responsiveness to C5 in adult C5-deficient DBA/2 mice.

van den Berg CW, Hofhuis FM, Rademaker PM, van Dijk H.

Immunology. 1991 Nov;74(3):380-5.

19.

C3- and T-cell-dependent adjuvant activity of in vivo formed immune complexes.

Van den Berg CW, Hazenberg MA, Hofhuis FM, Van Rooyen SM, Van Dijk H.

Immunology. 1991 Jul;73(3):264-70.

20.

C5 does not play a major role in the immune response of mice to SRBC in vivo.

van den Berg CW, van Horssen PJ, Hofhuis FM, Aerts PC, van Dijk H.

Scand J Immunol. 1991 May;33(5):621-6.

PMID:
2031152
21.

Induction of auto-antibody formation in C3H/HeJ mice by cobra venom factor.

Bloembergen P, Hol C, Hofhuis FM, van Dijk H.

Int Arch Allergy Appl Immunol. 1991;96(2):113-8.

PMID:
1769741
22.

Endotoxin-induced auto-immunity in mice. III. Comparison of different endotoxin preparations.

Bloembergen P, Hofhuis FM, Hol C, van Dijk H.

Int Arch Allergy Appl Immunol. 1990;92(2):124-30.

PMID:
2242926
23.

Macroscopic and microscopic early effects of tumour necrosis factor on murine Meth A sarcoma, and relation to curative activity.

Van de Wiel PA, Bloksma N, Kuper CF, Hofhuis FM, Willers JM.

J Pathol. 1989 Jan;157(1):65-73.

PMID:
2921668
24.
25.

Multiple facets of induction of tumour necrosis.

Bloksma N, van de Wiel PA, Kuper CF, Hofhuis FM.

Ann Inst Pasteur Immunol. 1988 May-Jun;139(3):294-9. Review. No abstract available.

PMID:
3048312
26.

Endotoxin-induced auto-immunity in mice. II. Reactivity of LPS-hyporesponsive and C5-deficient animals.

Bloembergen P, van Dijk H, Hofhuis FM, van den Heiligenberg P, Willers JM.

Int Arch Allergy Appl Immunol. 1988;86(4):370-4.

PMID:
3410556
27.

Antitumor effects of endotoxin against solid murine Meth A tumors of different ages. Quantitative histology of the tumors and regional lymph nodes.

Kuper CF, Bloksma N, Bruyntjes JP, Hofhuis FM.

Virchows Arch B Cell Pathol Incl Mol Pathol. 1988;56(1):51-8.

PMID:
2907202
28.
29.

Endotoxin-induced auto-immunity in mice. I. Time and dose dependence of production and serum levels of antibodies against bromelain-treated mouse erythrocytes and circulating immune complexes.

Bloembergen P, Hofhuis FM, van Dijk H, Verhagen C, Rademaker PM, Willers JM.

Int Arch Allergy Appl Immunol. 1987;84(3):291-7.

PMID:
3654010
30.

Quantitative histology of muramyl dipeptide-potentiated induction of tumor necrosis by endotoxins.

Kuper CF, Bloksma N, Bruyntjes JP, Hofhuis FM.

Virchows Arch B Cell Pathol Incl Mol Pathol. 1987;53(5):316-23.

PMID:
2889295
31.

Effects of endotoxin-treatment on inflammatory cell infiltrates in murine Meth A sarcoma.

Kuper CF, Bloksma N, Bruyntjes JP, Hofhuis FM, Wolterink G.

J Pathol. 1985 Sep;147(1):41-8.

PMID:
3900319
32.

Muramyl dipeptide analogues as potentiators of the antitumor action of endotoxin.

Bloksma N, Hofhuis FM, Willers JM.

Cancer Immunol Immunother. 1985;19(3):205-10.

PMID:
3847290
33.

Is tumor necrosis factor a physiological mediator?

Bloksma N, Hofhuis FM, Willers JM.

Immunol Today. 1984 Dec;5(12):338-9. doi: 10.1016/0167-5699(84)90071-9. No abstract available.

PMID:
25290972
34.

Role of vasoactive amines in the antitumor activity of endotoxin.

Bloksma N, Kuper CF, Hofhuis FM, Willers JM.

Immunopharmacology. 1984 Jun;7(3-4):201-9.

PMID:
6469605
35.

Endotoxin-induced antitumor activity in the mouse is highly potentiated by muramyl dipeptide.

Bloksma N, Hofhuis FM, Willers JM.

Cancer Lett. 1984 Jun;23(2):159-65.

PMID:
6378362
36.

Role of mononuclear phagocyte function in endotoxin-induced tumor necrosis.

Bloksma N, Hofhuis FM, Willers JM.

Eur J Cancer Clin Oncol. 1984 Mar;20(3):397-403.

PMID:
6368247
37.

Muramyl dipeptide is a powerful potentiator of the antitumor action of various tumor-necrotizing agents.

Bloksma N, Hofhuis FM, Willers JM.

Cancer Immunol Immunother. 1984;17(3):154-9.

PMID:
6566601
38.

Antitumour activity of endotoxin, concanavalin A and poly I: C and their ability to elicit tumour necrosis factor, cytostatic factors, and interferon in vivo.

Bloksma N, Kuper CF, Hofhuis FM, Benaissa-Trouw B, Willers JM.

Cancer Immunol Immunother. 1983;16(1):35-9.

PMID:
6196106
39.

Effects of various coryneforms on mononuclear phagocyte system function and on production of tumour necrosis factor in mice.

Bloksma N, de Leeuw R, Hofhuis FM, Westerdaal NA, Benaissa-Trouw B, Willers JM.

Ann Immunol (Paris). 1983 Jan-Feb;134C(1):159-64.

PMID:
6190428
40.

Prolongation of acquired cellular resistance to Listeria monocytogenes.

Willers JM, Hofhuis FM, Van der Meer C.

Immunology. 1982 Aug;46(4):787-92. No abstract available.

41.
42.
43.

Influence of adrenoceptor blockade on endotoxin-induced histopathological changes in murine Meth A sarcoma.

Kuper CF, Bloksma N, Hofhuis FM, Bruyntjes JP, Willers JM.

Int J Immunopharmacol. 1982;4(1):49-55.

PMID:
6123488
44.
45.

Effects of lactobacilli on parameters of non-specific resistance of mice.

Bloksma N, Ettekoven H, Hofhuis FM, van Noorle-Jansen L, De Reuver MJ, Kreeftenberg JG, Willers JM.

Med Microbiol Immunol. 1981;170(1):45-53.

PMID:
6795431
46.

Killed Listeria monocytogenes vaccine is protective in C3H/HeJ mice without addition of adjuvants.

van Dijk H, Hofhuis FM, Berns EM, van der Meer C, Willers JM.

Nature. 1980 Aug 14;286(5774):713-4. No abstract available.

PMID:
6774260
48.

Regulation of the immune response by macrophages.

Willers JM, Bloksma N, van der Meer C, Snippe H, van Dijk H, de Reuver MJ, Hofhuis FM.

Antonie Van Leeuwenhoek. 1979;45(1):41-8.

PMID:
95385
49.

Killed Listeria monocytogenes vaccine becomes protective on addition of polyanions.

Van Der Meer C, Hofhuis FM, Willers JM.

Nature. 1977 Oct 13;269(5629):594-5. No abstract available.

PMID:
411046
50.

Supplemental Content

Loading ...
Support Center